TULSA, Okla., Aug. 8, 2005 (PRIMEZONE) -- Maxxon, Inc. (Pink Sheets:MXON) ("Maxxon") announced today that a form 15c211 has been prepared for a market maker to file on their behalf so that Maxxon can become listed on the Over the Counter Bulletin Board.
The Company has complied with the reporting requirements of the Securities Exchange Act of 1934 for approximately three years and is currently applying for its OTC Bulletin Board listing and will continue to maintain a "fully reporting" status thereafter. Maxxon's filings can be accessed on www.sec.gov and www.edgar-online.com. While Maxxon's ability to trade on the Over the Counter Bulletin Board depends on a number of factors, many beyond its control, the Company has taken steps to achieve this objective. In the meantime, it is adopting a "news blackout" policy until the public filings are made, during which time it will make very few, if any, additional public statements concerning the listing process.
Maxxon recently entered into a 50/50 Joint Venture, with Globe Med Tech, to produce and/or distribute several new safety medical products including its ReVac Safety Syringe, Auto Retractable Safety Scalpel with Permanent Lock, and the Auto Retractable Safety IV. Several of the patented products use vacuum force to operate automatic retractable technology. The company feels that it will be able to market itself as a growing medical products designer, manufacturer and distributor that creates innovative devices which will have a price advantage over its competitors in the medical products arena in order to facilitate qualified monthly income, resulting in significant shareholder growth.
"This is certainly an exciting time for Maxxon and our shareholders; our move to OTCBB should increase our visibility, improve liquidity, and enhance awareness about the strong mix of high quality medical products we offer," stated Ron Wheet, CEO of Maxxon.
About Maxxon
Maxxon is a development stage company committed to reducing the risk of accidental needlestick injuries and deaths to healthcare workers. Maxxon's 3cc. safety syringe, presently in development, is designed as a single-handed, vacuum-operated safety syringe that retracts the used needle into the syringe after use.
For more information on Maxxon please go to www.maxxoninc.com
About Globe Med Tech
Globe Med Tech, Inc. is a high-tech medical safety and drug delivery products developer and manufacturer based in Houston, Texas, with a clean-room manufacturing presence in China. Globe has marketed its products in the U.S. and around the world, providing the medical industry with innovative low-cost, high-quality medical products. Globe's team has accumulated valuable integration experience for medical devices, while establishing itself as a cost effective operator in the medical device industry. Whether under the company's brand name, or under a private label, Globe has a history of effectively integrating patent development, research, and engineering design capabilities.
For more information on Globe please go to www.globemedtech.com .
Shareholders and other interested investors who would like to receive the Maxxon monthly newsletter, as well as an e-mail of Maxxon press releases when they are released, please sign up at http://www.idmcorp.us/Members/ .
This press release contains some forward-looking statements. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Forward-looking statements in this document should be evaluated together with the many uncertainties that affect our business. Those uncertainties are discussed in Maxxon's SEC filings.